1. Analysis of status and countermeasures of cancer incidence and mortality in China;Wu;Sci. China Life Sci.,2019
2. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019
3. NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes;Singh;Clin. Cancer Res.,2020
4. Perioperative targeted therapy or immunotherapy in non-small-cell lung cancer;Sa;OncoTargets Ther.,2019
5. Nivolumab monotherapy and nivolumab plus ipilimumab in recurrent small cell lung cancer: results from the CheckMate 032 randomized cohort;Ready;J. Thorac. Oncol.,2019